Investing Clinical trial data shows RAD 101 detects Brain Metastases February 10, 2025 Share Share on Facebook Share on Twitter Pinterest Email Radiopharm Theranostics (RAD:AU) has announced Clinical trial data shows RAD 101 detects Brain Metastases Download the PDF here. This post appeared first on investingnews.com 0 Prev Post MOU signed with Lafarge Canada Inc. February 10, 2025 Next Post High-Grades up to 65g/t Au at Second Fortune Gold Mine February 10, 2025 Related Posts Syntholene Selects Papadakis Engineering as Integration Partner for Novel Thermal-Hybrid Synthetic Fuel Demonstration Facility Heat Exchanger System March 13, 2026 Summit Royalties Announces Agreement to Acquire Royalty on Newmont’s Saddle North Deposit March 13, 2026 Lahontan Announces Private Placement March 13, 2026
Syntholene Selects Papadakis Engineering as Integration Partner for Novel Thermal-Hybrid Synthetic Fuel Demonstration Facility Heat Exchanger System March 13, 2026
Summit Royalties Announces Agreement to Acquire Royalty on Newmont’s Saddle North Deposit March 13, 2026
